Alpelisib FDA approval date

The FDA approved Alpelisib (BYL719) on 24 May 2019.

FDA approval date
24 May 2019

Drug identity checked against registry records

Also recorded as BYL719; Piqray; Vijoice

Included trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2019-05-24DayAlpelisibFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA212526", "applicant_as_listed_by_fda": "NOVARTIS", "brand_names": ["PIQRAY"], "active_ingredients": ["ALPELISIB"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20190524", "matched_on": "drug name equals FDA sole active ingredient"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026